Prevention of experimental septic shock by pretreatment of mice with muramyl peptides

International Immunopharmacology

Volumn 1, Issue 9-10, 2001, Pages 1857-1865

  Meshcheryakova, E ^a   Guryanova, S ^a   Makarov, E ^a   Alekseeva, L ^a   Andronova, T ^a   Ivanov, V ^a  

^a SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

Author keywords

Muramyl peptides; Protection; Septic shock

Indexed keywords

GLYCOPEPTIDE; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; MURAMYL PEPTIDE; MUROCTASIN; N ACETYL DEXTRO GLUCOSAMINYL (BETA1-4) N ACETYLMURAMYLALANYL DEXTRO GLUTAMIC ACID; N ACETYL DEXTRO GLUCOSAMINYL (BETA1-4) N ACETYLMURAMYLALANYL DEXTRO GLUTAMIC ACID DIBENZYL ESTER; N ACETYL DEXTRO GLUCOSAMINYL (BETA1-4) N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINE; N ACETYL DEXTRO GLUCOSAMINYL (BETA1-4) N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINYL EPSILON STEAROYLLYSINE; N ACETYL DEXTRO GLUCOSAMINYL N ACETYLMURAMYL DIPEPTIDE; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINE; PEPTIDE DERIVATIVE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INDUCTION; FEMALE; HYDROPHILICITY; INFECTION PREVENTION; LETHAL DOSE; LETHALITY; LIPOPHILICITY; MACROPHAGE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; SEPTIC SHOCK; TARGET CELL; TOXICITY;

ACETYLMURAMYL-ALANYL-ISOGLUTAMINE; ADJUVANTS, IMMUNOLOGIC; ANIMALS; ENDOTOXINS; FEMALE; GLYCOPEPTIDES; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; PHAGOCYTOSIS; SHOCK, SEPTIC; STEREOISOMERISM; SURVIVAL ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034881365     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(01)00111-4     Document Type: Article

References (26)

1. The role of cytokines in host responses to endotoxin
2. The role of cytokines in endotoxin-mediated responses
3. Induction of tolerance to lipopolysaccharide (LPS)-d-galactosamine lethality by pretreatment with LPS is mediated by macrophages
4. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin
5. Biological properties of a new synthetic adjuvant muramyl peptides (MDP)
6. Natural and synthetic immunomodulators derived from the mycobacterial cell wall
7. Macrophage activation by muramyl peptides
8. Synthetic muramyl peptide immunostimulants: Protective effects and increased efficacy of antibiotics in experimental bacterial and fungal infections in mice
9. Lipopolysaccharide hyperreactivity of animals infected with Tripanosoma lewisi or Tripanosoma musculi
10. Bacteroides lipopolysaccharide (LPS) induce anaphylactoid and lethal reactions in LPS-responsive and -nonresponsive mice primed with muramylpeptide
11. The mechanism of action and clinical efficiency of immunomodulator glucosaminylmuramyl dipeptide (licopid)
12. Chemical synthesis of N-acetylmuramyl peptides with partial structures of bacterial cell wall and their analogs in relation to immunoadjuvant activities
13. Synthesis and antitumor activity of glycopeptides containing N-acetylglucosaminyl-(β 1-4)-N-acetylmuramyl disaccharide unit
14. Structure-function investigation of glucosamuramyl peptides. Influence of chemical modification of N-acetylglucosaminyl-N-acetylmuramyl dipeptide (GMDP) on its immunomodulatory properties in vivo and in vitro
15. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
16. The structure and immunomodulating function of glycosaminylmuramyl peptides
17. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and d-galactosamine-treated mice
18. The role of cachectin/TNF in endotoxic shock and cachexia
19. Tolerance to tumor necrosis factor in rats and relationship to endotoxin tolerance and toxicity
20. MDP and LPS act synergistically to induce arginine-dependent cytostatic activity in rat alveolar macrophages
21. Cachectin and tumor necrosis factor as two sides of the same biological coin
22. Shock and tissue injury induced by recombinant human cachectin
23. Specific binding of soluble peptidoglican and muramyldipeptide to CD14 on human monocytes
24. Cutting edge: Recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2
25. Interactions of CD14 with components of Gram-positive bacteria